摘要
目的 探究中国甲状腺影响报告和数据系统(C-TIRADS)对甲状腺囊性、囊实性机化皱缩结节与甲状腺乳头状癌的鉴别价值。方法 回顾性分析收治的疑似甲状腺乳头状癌患者共计106例,采用C-TIRADS系统对其进行评估,以穿刺细胞学检查或手术后病理科组织切片分析为金标准,根据金标准将纳入研究对象分为皱缩结节组(n=59)以及乳头状癌组(n=47);将系统鉴别结果与最终诊断结果进行对比,对C-TIRADS的鉴别价值进行评判。结果 两组患者接受C-TIRADS判定指标中,垂直位、实性、可疑微钙化、边缘模糊、彗星尾伪像指标的病例数占比均具有统计学差异(P<0.05),极低回声病例数占比差异无统计学意义(P>0.05);各项分类(4A、4B、4C以及5类)结果中,皱缩结节组以及乳头状癌组病例数占比均存在统计学差异(P<0.05)。结论 C-TIRADS分类对于甲状腺结节的良性、恶性判断具有良好的评估价值,可实施性强,值得临床的借鉴应用。
Objective To explore the differential value of Chinese thyroid imaging reporting and data system(C-TIRADS) for cystic, solid-cystic thyroid organized shrinkage nodules and papillary thyroid carcinoma.Methods A total of 106 patients with suspected papillary thyroid carcinoma admitted to the hospital were retrospectively analyzed.All were evaluated by C-TIRADS.Taking The results of puncture cytology or histopathologic slide analysis as the golden standard.According to the golden standard, they were divided into shrinkage nodule group(n=59) and papillary carcinoma group(n=47).The results of system identification and the final diagnosis were compared.The differential value of C-TIRADS was determined.Results The differences in proportion of cases with C-TIRADS signs(vertical position, solid, suspected micro-calcification, edge blur, omet-tail artifact) between the 2 groups were statistically significant(P<0.05),but there was no significant difference in the proportion of cases with extremely low echo between the 2 groups(P>0.05).The differences in proportion of cases with different classifications(4A,4B,4C,type 5),between shrinkage nodule group and papillary carcinoma group were statistically significant(P<0.05).Conclusion C-TIRADS classification has good evaluation value for benign and malignant thyroid nodules, with high implementation.
作者
赵静
张鑫
王灵悦
Zhao Jing;Zhang Xin;Wang Lingyue(The Third People's Hospital of Henan,Zhengzhou,450003)
出处
《实用癌症杂志》
2023年第3期488-490,495,共4页
The Practical Journal of Cancer
关键词
甲状腺影响报告和数据系统
甲状腺机化皱缩结节
甲状腺乳头状癌
Chinese thyroid imaging reporting and data system
Thyroid organized shrinkage nodule
Papillary thyroid carcinoma